Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.

CONCLUSION: In a routine haematological practice, the use of eltrombopag in AA patients was feasible, safe, and associated with very favourable responses.
PMID: 29303047 [PubMed - as supplied by publisher]

Source: Hematology - January 7, 2018 Category: Hematology Tags: Hematology Source Type: research